<?xml version="1.0" encoding="UTF-8"?>
<fn-group>
 <fn fn-type="abbr">
  <p>Abbreviations: BIA = bioelectrical impedance analysis, CK-MB = creatine kinase-myocardial band, CRP = C-reactive protein, CSA = cross-sectional area, ELISA = enzyme-linked immunosorbent assays, EORTC QLQ-C30 = European Organization for the Research and Treatment of Cancer, HAD = 3-hydroxyacyl-CoA-dehydrogenase, IFN-γ = interferon gamma, IL-6, IL-15, IL-8, IL-10, IL-1β = interleukin- 6,15,8, 10 and 1beta, MFI = multidimensional fatigue inventory, mTOR = mechanistic target of rapamycin, p62 = ubiquitin-binding protein p62, QLQ-BR25 = The European organization for research and treatment of cancer quality, of life questionnaire, Quality of Life Questionnaire Core 30, RT = resistance training, SC = satellite cell, SPARC = secreted protein acidic and rich in cysteine (osteonectin), SWA = sensewear armband, TNF-α = tumor necrosis factor alpha, TWEAK = TNF-related weak inducer of apoptosis, VO
   <sup>2</sup>max = maximal oxygen uptake.
  </p>
 </fn>
 <fn fn-type="other">
  <p>How to cite this article: Strandberg E, Vassbakk-Svindland K, Henriksson A, Johansson B, Vikmoen O, Kudrén D, Schauer T, Lindman H, Wärnberg F, Berntsen S, Demmelmaier I, Nordin K, Raastad T. Effects of heavy-load resistance training during (neo-)adjuvant chemotherapy on muscle cellular outcomes in women with breast cancer. 
   <italic>Medicine</italic>. 2021;100:10(e24960).
  </p>
 </fn>
 <fn fn-type="supported-by">
  <p>This study is supported by the Swedish Cancer Society (18–0356) and Kreftforeningen (198149–2018), Norway. The funders will not have a role in the study design, execution, analyses, interpretation of the data, or the decision to submit results.</p>
 </fn>
 <fn fn-type="COI-statement">
  <p>The authors have no conflicts of interests to disclose.</p>
 </fn>
 <fn fn-type="other">
  <p>The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.</p>
 </fn>
</fn-group>
